vs
Harmony Biosciences Holdings, Inc.（HRMY）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是Harmony Biosciences Holdings, Inc.的1.9倍（$461.6M vs $243.8M），RBC Bearings INC净利率更高（14.6% vs 9.2%，领先5.4%），Harmony Biosciences Holdings, Inc.同比增速更快（21.1% vs 17.0%），Harmony Biosciences Holdings, Inc.自由现金流更多（$126.0M vs $99.1M），过去两年Harmony Biosciences Holdings, Inc.的营收复合增速更高（25.6% vs 5.6%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
HRMY vs RBC — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $461.6M |
| 净利润 | $22.5M | $67.4M |
| 毛利率 | 71.9% | 44.3% |
| 营业利润率 | 15.8% | 22.3% |
| 净利率 | 9.2% | 14.6% |
| 营收同比 | 21.1% | 17.0% |
| 净利润同比 | -54.6% | 16.4% |
| 每股收益（稀释后） | $0.38 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $243.8M | $461.6M | ||
| Q3 25 | $239.5M | $455.3M | ||
| Q2 25 | $200.5M | $436.0M | ||
| Q1 25 | $184.7M | $437.7M | ||
| Q4 24 | $201.3M | $394.4M | ||
| Q3 24 | $186.0M | $397.9M | ||
| Q2 24 | $172.8M | $406.3M | ||
| Q1 24 | $154.6M | $413.7M |
| Q4 25 | $22.5M | $67.4M | ||
| Q3 25 | $50.9M | $60.0M | ||
| Q2 25 | $39.8M | $68.5M | ||
| Q1 25 | $45.6M | $72.7M | ||
| Q4 24 | $49.5M | $57.9M | ||
| Q3 24 | $46.1M | $54.2M | ||
| Q2 24 | $11.6M | $61.4M | ||
| Q1 24 | $38.3M | — |
| Q4 25 | 71.9% | 44.3% | ||
| Q3 25 | 75.1% | 44.1% | ||
| Q2 25 | 81.0% | 44.8% | ||
| Q1 25 | 82.7% | 44.2% | ||
| Q4 24 | 73.0% | 44.3% | ||
| Q3 24 | 77.0% | 43.7% | ||
| Q2 24 | 81.4% | 45.3% | ||
| Q1 24 | 82.2% | 43.1% |
| Q4 25 | 15.8% | 22.3% | ||
| Q3 25 | 27.3% | 21.5% | ||
| Q2 25 | 24.0% | 23.2% | ||
| Q1 25 | 30.4% | 23.0% | ||
| Q4 24 | 27.7% | 21.7% | ||
| Q3 24 | 33.2% | 21.6% | ||
| Q2 24 | 12.4% | 24.0% | ||
| Q1 24 | 33.7% | 22.8% |
| Q4 25 | 9.2% | 14.6% | ||
| Q3 25 | 21.2% | 13.2% | ||
| Q2 25 | 19.8% | 15.7% | ||
| Q1 25 | 24.7% | 16.6% | ||
| Q4 24 | 24.6% | 14.7% | ||
| Q3 24 | 24.8% | 13.6% | ||
| Q2 24 | 6.7% | 15.1% | ||
| Q1 24 | 24.8% | — |
| Q4 25 | $0.38 | $2.13 | ||
| Q3 25 | $0.87 | $1.90 | ||
| Q2 25 | $0.68 | $2.17 | ||
| Q1 25 | $0.78 | $2.33 | ||
| Q4 24 | $0.85 | $1.82 | ||
| Q3 24 | $0.79 | $1.65 | ||
| Q2 24 | $0.20 | $1.90 | ||
| Q1 24 | $0.67 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $107.6M |
| 总债务越低越好 | $163.7M | $990.2M |
| 股东权益账面价值 | $870.2M | $3.3B |
| 总资产 | $1.3B | $5.1B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.30× |
8季度趋势，按日历期对齐
| Q4 25 | $775.3M | $107.6M | ||
| Q3 25 | $672.6M | $91.2M | ||
| Q2 25 | $565.3M | $132.9M | ||
| Q1 25 | $507.0M | $36.8M | ||
| Q4 24 | $467.2M | — | ||
| Q3 24 | $410.5M | — | ||
| Q2 24 | $346.9M | $76.8M | ||
| Q1 24 | $372.4M | $63.5M |
| Q4 25 | $163.7M | $990.2M | ||
| Q3 25 | $168.5M | $1.1B | ||
| Q2 25 | $172.1M | $915.6M | ||
| Q1 25 | $175.7M | $920.1M | ||
| Q4 24 | $179.3M | — | ||
| Q3 24 | $182.8M | — | ||
| Q2 24 | $186.4M | — | ||
| Q1 24 | $190.0M | $1.2B |
| Q4 25 | $870.2M | $3.3B | ||
| Q3 25 | $835.1M | $3.2B | ||
| Q2 25 | $773.1M | $3.1B | ||
| Q1 25 | $720.5M | $3.0B | ||
| Q4 24 | $659.2M | $2.9B | ||
| Q3 24 | $596.8M | $2.9B | ||
| Q2 24 | $538.6M | $2.8B | ||
| Q1 24 | $515.4M | $2.8B |
| Q4 25 | $1.3B | $5.1B | ||
| Q3 25 | $1.2B | $5.1B | ||
| Q2 25 | $1.1B | $4.8B | ||
| Q1 25 | $1.1B | $4.7B | ||
| Q4 24 | $999.2M | $4.7B | ||
| Q3 24 | $928.1M | $4.7B | ||
| Q2 24 | $858.4M | $4.7B | ||
| Q1 24 | $847.0M | $4.7B |
| Q4 25 | 0.19× | 0.30× | ||
| Q3 25 | 0.20× | 0.34× | ||
| Q2 25 | 0.22× | 0.29× | ||
| Q1 25 | 0.24× | 0.30× | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.37× | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $126.0M | $99.1M |
| 自由现金流率自由现金流/营收 | 51.7% | 21.5% |
| 资本支出强度资本支出/营收 | 0.0% | 5.0% |
| 现金转化率经营现金流/净利润 | 5.61× | 1.81× |
| 过去12个月自由现金流最近4个季度 | $347.9M | — |
8季度趋势，按日历期对齐
| Q4 25 | $126.2M | $122.1M | ||
| Q3 25 | $108.7M | $88.4M | ||
| Q2 25 | $79.3M | $120.0M | ||
| Q1 25 | $34.0M | — | ||
| Q4 24 | $75.6M | $84.0M | ||
| Q3 24 | $70.5M | — | ||
| Q2 24 | $42.6M | $97.4M | ||
| Q1 24 | $31.1M | — |
| Q4 25 | $126.0M | $99.1M | ||
| Q3 25 | $108.7M | $71.7M | ||
| Q2 25 | $79.3M | $104.3M | ||
| Q1 25 | $33.9M | — | ||
| Q4 24 | $75.0M | $73.6M | ||
| Q3 24 | $70.5M | — | ||
| Q2 24 | $42.0M | $88.4M | ||
| Q1 24 | $31.1M | — |
| Q4 25 | 51.7% | 21.5% | ||
| Q3 25 | 45.4% | 15.7% | ||
| Q2 25 | 39.6% | 23.9% | ||
| Q1 25 | 18.3% | — | ||
| Q4 24 | 37.3% | 18.7% | ||
| Q3 24 | 37.9% | — | ||
| Q2 24 | 24.3% | 21.8% | ||
| Q1 24 | 20.1% | — |
| Q4 25 | 0.0% | 5.0% | ||
| Q3 25 | 0.0% | 3.7% | ||
| Q2 25 | 0.0% | 3.6% | ||
| Q1 25 | 0.1% | 3.2% | ||
| Q4 24 | 0.3% | 2.6% | ||
| Q3 24 | 0.0% | 4.1% | ||
| Q2 24 | 0.4% | 2.2% | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 5.61× | 1.81× | ||
| Q3 25 | 2.14× | 1.47× | ||
| Q2 25 | 1.99× | 1.75× | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 1.53× | 1.45× | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 3.68× | 1.59× | ||
| Q1 24 | 0.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRMY
暂无分部数据
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
